These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 30205384)

  • 1. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
    Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
    Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
    Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
    Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
    J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.
    Wang Z; Zhu X; Dong P; Cai J
    Life Sci; 2020 Feb; 242():116782. PubMed ID: 31442551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.